Biomarker analysis of the LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) in metastatic triple-negative breast cancer (TNBC) Meeting Abstract
| Authors: | Wongchenko, M. J.; Dent, R.; Kim, S. B.; Saura, C.; Oliveira, M.; Baselga, J.; Kapp, A. V.; Chan, W. Y.; Singel, S. M.; Maslyar, D. J.; Gendreau, S. |
| Abstract Title: | Biomarker analysis of the LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) in metastatic triple-negative breast cancer (TNBC) |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489400267 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-P2-09-20 |
| Notes: | Meeting Abstract: P2-09-20 -- Source: Wos |
